1. Home
  2. VREX vs ASMB Comparison

VREX vs ASMB Comparison

Compare VREX & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

N/A

Current Price

$10.86

Market Cap

580.6M

Sector

Technology

ML Signal

N/A

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$28.30

Market Cap

440.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VREX
ASMB
Founded
2016
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
580.6M
440.0M
IPO Year
2016
2010

Fundamental Metrics

Financial Performance
Metric
VREX
ASMB
Price
$10.86
$28.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$43.40
AVG Volume (30 Days)
334.0K
92.6K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
0.05
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
$33.33
Revenue Next Year
$3.88
N/A
P/E Ratio
$225.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$7.76
52 Week High
$14.57
$39.71

Technical Indicators

Market Signals
Indicator
VREX
ASMB
Relative Strength Index (RSI) 21.12 48.18
Support Level $10.81 $26.50
Resistance Level $12.61 $30.66
Average True Range (ATR) 0.43 1.46
MACD -0.27 0.04
Stochastic Oscillator 2.97 36.74

Price Performance

Historical Comparison
VREX
ASMB

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: